Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV [Phase 1]

View source ↗

Summary

This is a Phase 1 study update assessing VH3810109 with or without fostemsavir in people living with HIV, aiming to reduce the HIV viral reservoir. The trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fostemsavir (fostemsavir)
  • VH3810109 (VH3810109)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: ACTIVE_NOT_RECRUITING